MedPath

Efficacy and safety of adjunctive midazolam with propofol-based TCI for sedated colonoscopy

Phase 1
Conditions
Propofol consumption , Hypotension while under anesthesia forcolonoscopy
Target-controlled infusion, Sedation for colonoscopy, Medzolam,
Registration Number
TCTR20230707002
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
92
Inclusion Criteria

1 Patients undergoing elective colonoscopy
2 ASA status I - III

Exclusion Criteria

1 BMI > 35 kg/m2
2 Colostomy patients
3 Patients on epilepsy drug or benzodiazepines
4 Patients who have liver cirrhosis or end-stage kidney disease
5 Allergy to propofol, fentanyl, or benzodiazepine
6 Anticipated difficult airway

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath